Skip to content
Medasense Academy
Customer Support
  • NOL Index
    • Technology
    • Testimonials
  • PMD-200
    • Product
    • Product Resources
    • Tutorials
  • Clinical Resources
    • Peer-Reviewed Publications
    • Clinical Practice & Guidelines
    • Posters, Abstracts and Presentations
    • Review Articles
    • Case Reports
    • Clinical Guides and Manuals
    • Lectures
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Latest News
    • Latest News
    • Upcoming Events
    • Newsletter
    • Media Coverage
    • Contact
Menu
  • NOL Index
    • Technology
    • Testimonials
  • PMD-200
    • Product
    • Product Resources
    • Tutorials
  • Clinical Resources
    • Peer-Reviewed Publications
    • Clinical Practice & Guidelines
    • Posters, Abstracts and Presentations
    • Review Articles
    • Case Reports
    • Clinical Guides and Manuals
    • Lectures
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Latest News
    • Latest News
    • Upcoming Events
    • Newsletter
    • Media Coverage
    • Contact
Request a Demo

Newsdesk

Follow Medasense’s accomplishments and news

NOL Pain Response Monitoring Secures Marketing Approval in Brazil

October 28, 2020
Read More »

New Study: NOL Monitoring Can Help Reduce Postoperative Pain

September 29, 2020
Read More »

Medasense Raises $18M in Series C Round

September 22, 2020
Read More »

Economic Study Shows Cost Benefits of NOL Technology

September 17, 2020
Read More »

EU Prize for Women Innovators

July 13, 2020
Read More »
Page1 Page2 Page3 Page4 Page5 NEXT

Recent Social Media Posts

We're following the #PainTalk conversation.
How about you?#surgery #ICU #anesthesia https://t.co/KC6He2yBQm

— Medasense Biometrics (@MedasenseLtd) March 1, 2021
Keep up with the latest updates from Medasense
  • NOL Index
  • PMD-200
  • Clinical Resources
Menu
  • NOL Index
  • PMD-200
  • Clinical Resources
  • About Us
  • News
  • Contact
Menu
  • About Us
  • News
  • Contact

This is Medasense’s global website. The information presented on this website has not been evaluated by the FDA.

NOL technology is commercially available across Europe, Canada, Australia, South Africa, Israel and select Latin American countries.

Copyright © Medasense Biometrics Ltd.  All rights reserved.
Last updated March 2021

  • Privacy Policy
  • Terms & Conditions